AUPH News and Press, Aurinia Pharmaceuticals Inc From 04/19/20

Investing in biotech stocks can feel like a rollercoaster ride. Positive clinical trial results, drug approvals, or lucrative partnership announcements can send stocks soaring. These stocks can just as easily get eviscerated on drug failures, regulatory setbacks, and patent challenges. To rais...

Keeping tabs on the quarterly activity of billionaire superinvestors can be a great way to unearth hidden gems, or perhaps avoid potential potholes. Billionaires, after all, are rich for a reason. When it comes to the complex but rewarding area of healthcare, Baker Brothers Advisors, a hedge fun...

- Data to be shared as a late-breaking oral presentation during the live virtual NKF conference - Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclospo...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that the Company has established its U.S. commercial center ...

Aurinia Pharmaceuticals (NASDAQ: AUPH ) has initiated a rolling submission of its NDA for voclosporin, a next-generation calcineurin inhibitor for the treatment of lupus nephritis (“LN”). More news on: Aurinia Pharmaceuticals Inc., Healthcare stocks news, Read more ... ...

- Company remains on track to complete submission by the end of the second quarter 2020 - Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in mul...

- Company recognizes World Kidney Day and National Kidney Month - Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) , a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple inflammator...

OPKO Health to Offer Coronavirus Test, Shares Jump OPKO Health ( OPK ) reported that it will offer coronavirus tests through its BioReference Laboratories unit. The tests are expected to be available from next week onward. The company also reported that these tests will be offered througho...

Healthcare Pulse Source: Bloomberg The fear of Coronavirus (Covid-19) has infected the stock market. The market's patience completely ran out this week as the Coronavirus news, which has continued to weigh heavily on the negative side, sent the market reeling in a feral pullback. Wha...

- Industry veteran, Max Colao, appointed Chief Commercial Officer - - Recruited four seasoned executives with expertise across critical commercial functions - - Rapidly preparing for the potential commercialization of voclosporin during the first half of 2021 - Aurinia Pharm...